These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

452 related items for PubMed ID: 34196945

  • 21. Antipsychotic Polypharmacy: A Dirty Little Secret or a Fashion?
    Lin SK.
    Int J Neuropsychopharmacol; 2020 Feb 01; 23(2):125-131. PubMed ID: 31867671
    [Abstract] [Full Text] [Related]

  • 22. The expert consensus guideline series. Optimizing pharmacologic treatment of psychotic disorders. Introduction: methods, commentary, and summary.
    Kane JM, Leucht S, Carpenter D, Docherty JP, Expert Consensus Panel for Optimizing Pharmacologic Treatment of Psychotic Disorders.
    J Clin Psychiatry; 2003 Feb 01; 64 Suppl 12():5-19. PubMed ID: 14640142
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Subjective Medication Satisfaction With Antipsychotic Polypharmacy in a Naturalistic Inpatient and Outpatient Sample.
    Kikkert MJ, de Mooij L, de Koning M, Dekker J.
    J Clin Psychiatry; 2021 Dec 21; 83(1):. PubMed ID: 34936243
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Long-acting injectable antipsychotics in the elderly: guidelines for effective use.
    Masand PS, Gupta S.
    Drugs Aging; 2003 Dec 21; 20(15):1099-110. PubMed ID: 14651433
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Antipsychotic polypharmacy in the treatment of schizophrenia in China and Japan.
    Qiu H, He Y, Zhang Y, He M, Liu J, Chi R, Si T, Wang H, Dong W.
    Aust N Z J Psychiatry; 2018 Dec 21; 52(12):1202-1212. PubMed ID: 30309245
    [Abstract] [Full Text] [Related]

  • 33. Effectiveness of switching from antipsychotic polypharmacy to monotherapy.
    Essock SM, Schooler NR, Stroup TS, McEvoy JP, Rojas I, Jackson C, Covell NH, Schizophrenia Trials Network.
    Am J Psychiatry; 2011 Jul 21; 168(7):702-8. PubMed ID: 21536693
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Antipsychotic polypharmacy in patients with schizophrenia in a brief hospitalization unit.
    Lerma-Carrillo I, de Pablo Brühlmann S, del Pozo ML, Pascual-Pinazo F, Molina JD, Baca-García E.
    Clin Neuropharmacol; 2008 Jul 21; 31(6):319-32. PubMed ID: 19050409
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Evaluation of the individual safe correction of antipsychotic agent polypharmacy in Japanese patients with chronic schizophrenia: validation of safe corrections for antipsychotic polypharmacy and the high-dose method.
    Yamanouchi Y, Sukegawa T, Inagaki A, Inada T, Yoshio T, Yoshimura R, Iwata N.
    Int J Neuropsychopharmacol; 2014 Dec 11; 18(5):. PubMed ID: 25522380
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 23.